Skip to main content

August 2016

 

 

academics

 

Clinical research courses

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral use, CII for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. TROXYCA ER has properties that are expected to reduce abuse when crushed and administered by the oral and intranasal routes. However, abuse of TROXYCA ER by these routes is still possible. It is the only oxycodone with oral abuse-deterrent features described in the labeling.

(adsbygoogle = window.adsbygoogle || []).push({});

AstraZeneca and Eli Lilly and Company (Lilly) today announced they have received US Food and Drug Administration (FDA) Fast Track designation for the development programme in Alzheimer’s disease for AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in Phase III clinical trial.

Recruitment for Pharmacists (66 Posts) under Health & Family Welfare Society - walk in

The history of municipal governance of Bangalore dates back to March 27, 1862, when nine leading citizens of the city formed a Municipal Board under the Improvement of Towns Act of 1850. Later, a similar Municipal Board was also formed in the Cantonment area of the city. The two boards were legalized in 1881, and functioned as two independent bodies called the Bangalore City Municipality and the Bangalore Civil and Military Station Municipality.

Vacancy for Clinical Project Administrator at Covance

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Post: Clinical Project Administrator

Vacancy as Production Officer in Colorcon

Colorcon is a world leader in the development, supply and technical support of formulated coatings and other excipients for the pharmaceutical and dietary/food/nutritional supplement industries. Our best-in-class products and pharmaceutical technologies are complemented by our value-added services which support all phases of solid oral dose design and development.

Post: Production Officer

Career as Pharmacist Cum Data Assistant in National Health Mission

National Health Mission (NHM) encompassing two Sub-Missions, National Health Mission (NHM) and National Urban Health Mission (NUHM). It is both flexible and dynamic and is intended to guide States towards ensuring the achievement of universal access to health care through strengthening of health systems, institutions and capabilities.

Post : Pharmacist Cum Data Assistant (AYUSH Pharmasy)

Work as Financial Analyst at Evolet Healthcare

Evolet Healthcare Pvt. Ltd. is an international, modern and dynamic outsourcing company that specializes in the field of contract manufacturing and marketing of pharmaceutical products. The Management of the company constantly monitors innovations in the pharmaceutical industry to keep up with the ever-increasing demands on pharmaceutical products to improve and enhance the quality of services irrespective of which part of the world the client comes from.
Evolet Healthcare Pvt. Ltd. has long-term contracts with manufacturers of pharmaceutical products, as well as with international pharmaceutical corporations and marketing companies that distribute its products in the markets of Asia, EU, CIS, Africa and Latin America.

Post : Financial Analyst

Xenetic Biosciences, Inc. announced that it has commenced a collaboration with Excivion Ltd. to develop a vaccine against Zika and dengue viruses. As part of the collaboration, Xenetic’s proprietary IMUXEN Technology will be used to develop the vaccine. Excivion is a private UK company that has developed a proprietary antigen design platform for viral vaccines which it is applying to flavivirus infections.

Edwards Lifesciences Corporation announced U.S. Food and Drug Administration (FDA) approval to expand use of the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients suffering from severe, symptomatic aortic stenosis who have been determined by a Heart Team to be at intermediate risk for open-heart surgery. The SAPIEN 3 valve is the first transcatheter aortic valve replacement (TAVR) therapy to obtain this indication in the United States.

Innovus Pharmaceuticals, Inc. announced  that its partner Khandelwal Laboratories received the approval of the product licenses for Zestra®, Zestra Glide®, EjectDelay® and Sensum+® from the Indian FDA, The Drugs Controller General (India), and the Directorate General of Health Services to commercialize the products in India.